Scintimammography using 99mTc sestamibi - Use and limitations;Die szintigraphie der mamma mit 99mTc-sestamibi - Indikationen und limitationen

NuklearMedizin

Volumn 41, Issue 3, 2002, Pages 148-156

  Tiling, Reinhold ^a   Linke, R ^a   Kessler M ^a   Untch, M ^a   Sommer, H ^a   Brinkbaumer K ^a   Becker, I ^a   Hahn, K ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Breast cancer; Scintimammography; Tc 99m sestamibi

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER REGRESSION; CANCER SCREENING; CANCER SIZE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG UPTAKE; EARLY DIAGNOSIS; ECHOMAMMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; PALPATION; PHYSICAL EXAMINATION; SCINTIMAMMOGRAPHY; SENSITIVITY AND SPECIFICITY; TREATMENT INDICATION; TUMOR BIOPSY;

EID: 0036083932     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1623890     Document Type: Article

References (46)

1. New methods for imaging the breast: Techniques, findings, and potential
2. Analysis of cancer missed at the screening mammography
3. 99mTc-MIBI: A comparative study with mammography and ultrasonography
4. Breast MR imaging with commercially available techniques: Radiologic-pathologic correlation
5. MR imaging of the breast: Current status and future potential
6. MR imaging of the breast with rotating delivery of excitation of resonance: Clinical experience with pathologic correlation
7. MR imaging of the breast with Gd-DTPA: Use and limitations
8. Contrast-material enhanced MRI of the breast in patients with postoperative scarring and silicon implants
9. Szintimammographie - Cui bono?
10. Contrast-enhanced MRI of the breast after limited surgery and radiation therapy
11. Contrast-enhanced magnetic resonance imaging of the breast
12. Early detection of breast cancer in women
13. Imaging of the radiographically dense breast
14. The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses
15. Scintimammography: The complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma
16. Technetium-99m-sestamibi scintimammography of breast lesions: Clinical and pathological follow-up
17. Review of imaging techniques for the diagnosis of breast cancer: A new role of prone scintimammography using technetium-99m sestamibi
18. 99mTc-sestamibi breast imaging: Multicenter trial results
19. MR mammography with pharmakokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy
20. The positive predictive value of mammography
21. MR-mammographie
22. The role of MRI in the assessment of local recurrent breast carcinoma
23. Tc-99m-tetrofosmin scintimammography: A prospective study in primary breast lesions
24. Technetium-99m-MIBI scintigraphy in the assessment of neoadjuvant chemotherapy in breast carcinoma
25. Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [Technetium 99m]-sestamibi scintimammography
26. Mammography in the assessment of response to medical treatment of large primary breast cancer
27. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation
28. Scintimammography with Technetium-99m methoxyisobutylisonitrile: Results of a prospective European multicenter trial
29. Scintimammography with technetium-99m methoxyisobutylisonitrile: Comparison with mammography and magnetic resonance imaging
30. Technetium-99m-MIBI scintimammography for suspicious breast lesions
31. Technetium-99m-methylene diphosphonate scintimammography to image primary breast cancer
32. MRI of breast cancer: Influence of chemotherapy on sensitivity
33. Advanced primary breast cancer: Assessment at mammography of response to induction chemotherapy
34. Mammographic features of 300 consecutive nonpalpable breast cancers
35. The epidemiology of breast cancer
36. Breast cancer staging with contrast material-enhanced MR imaging: Should it change patient treatment?
37. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement
38. Limited value of scintimammography and contrastenhanced MRI in the evaluation of microcalcification detected by mammography
39. Role of technetium-99m sestamibi scintimammography and contrast enhanced magnetic resonance imaging for the evaluation of indeterminate mammograms
40. 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: A comparative study
41. Comparison of Tc-99m sestamibi scintimammography with contrast enhanced MRI for the diagnosis of breast lesions
42. Primary breast cancer: Mammographic changes after neoadjuvant chemotherapy, with pathologic correlation
43. MR imaging of the breast